Spain
I advise business owners on strategic sales and acquisitions. A successful exit is not an event — it is a disciplined process built on preparation, positioning and controlled execution. On the sell-side, we: • Prepare the company for market • Define the equity story • Identify and qualify buyers • Run a structured process • Negotiate value and structure • Lead due diligence to closing On the buy-side, we: • Define acquisition strategy • Source proprietary targets • Engage owners directly • Structure and negotiate transactions • Execute disciplined due diligence As a former CEO with full P&L responsibility across Europe and the U.S., I understand what buyers value — and how to position companies accordingly. Through Sellside Group, we bring senior-level operating experience to every mandate. Focused. Controlled. Executed.
External Advisor to the Board of Directors at Metly, supporting strategy, industry partnerships, and growth initiatives.
Sellside Group is a management consulting company focused on M&A that works with either buyers or sellers through a multi-step process of preparation, search, closing and integration. We help business owners and management teams, grow the value of their businesses by bringing in investors, acquire suitable targets or sell their company.
https://www.thinkbionova.com I work with private equity firms and life sciences leadership teams to drive growth and unlock real value through focused, actionable strategy. With over 30 years leading transformations across pharma and biotech, I help companies sharpen their positioning, accelerate performance, and scale with purpose. I help companies unlock the power of their brands to drive strategic impact. As a board advisor, I bring independent perspective, challenge assumptions, and keep boards focused on what matters most: growth, performance, and long-term value creation.
Led global commercial strategy, driving double-digit revenue growth in rare diseases and specialty biotech. Oversaw corporate governance, risk management, and regulatory compliance, ensuring adherence to industry standards. Advised on capital allocation, M&A due diligence, and strategic partnerships, enhancing shareholder value. Spearheaded international market expansion, strengthening Sobi’s position in North America, Europe, and emerging markets.
Led operational turnaround and regulatory governance for a manufacturing plant, ensuring full compliance with EU and U.S. FDA standards. Developed and executed global expansion strategies, successfully penetrating new international markets. Designed and implemented corporate governance frameworks, risk management structures, and compliance policies. Supported M&A execution, optimizing Altan’s market position ahead of strategic transactions.